Atlas Trials

A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)

Clinical trial NCT00988624 · COMPLETED

Trial details

NCT number
NCT00988624
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's DiseaseHuntington Disease
Start date
2009-10-01
Primary completion
2009-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.